No need to ask what issue currently sits at the top of global priority “to do” lists. Around the world, the search is on for a suitable vaccine to stop the coronavirus spreading any further. Naturally, on top of saving lives and the accompanying kudos, will come the monetary reward. So, the race is on to find a viable solution, with several healthcare companies hoping to emerge victorious. One of those is Inovio Pharmaceuticals (INO).INO stock is up nearly 18% on the back of positive developments for its COVID-19 vaccination candidate. INO-4800 (the designated name for Inovio’s vaccine), will begin …read more
Source:: Yahoo Finance
